Study on the Safety and Pharmacokinetics of LM001 and Gonal-F® in Healthy Women
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
Brief Summary: LM001 is a recombinant human Follicle Stimulating Hormone (r-hFSH) Injection,
which is proposed for Assisted Reproductive Technology (ART). This is a randomized,
open-label, two-period, two-crossover study to evaluate the safety and pharmacokinetics of
recombinant human follicle stimulating hormone injection (LM001), compared with Gonal-F®,
both given subcutaneously.